The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Chickasaw Strategic Pointe, LLC with a potential value of $25 million to provide pharmacovigilance system implementation and information technology lifecycle support for the Adverse Event Reporting System II program. The single award contract has a period of performance through March 2024.
Under this contract, four firm fixed price delivery orders have been awarded to Chickasaw Strategic Pointe totaling over $27.5 million to provide information technology operations and maintenance support, requirements development, and data administration services essential to the FDA's post-market safety surveillance efforts. Services have been performed in Arkansas, Oklahoma, Maryland, and Maryland by the prime contractor. No subcontracting or set aside details were indicated in the materials provided. The delivery orders aim to ensure the FDA can effectively monitor safety issues with medical products through analysis of adverse event reports submitted to its Adverse Event Reporting System II.
Generated 1/4/24, 10:42 PM